General Information of the Compound
Compound ID
CP0574641
Compound Name
4-[3-oxo-4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-1H-pyridazin-6-one
    Show/Hide
Structure
Formula
C16H15F3N4O2
Molecular Weight
352.316
Canonical SMILES
FC(F)(F)c1ccccc1CN1CCN(CC1=O)c1cn[nH]c(=O)c1
    Show/Hide
InChI
InChI=1S/C16H15F3N4O2/c17-16(18,19)13-4-2-1-3-11(13)9-23-6-5-22(10-15(23)25)12-7-14(24)21-20-8-12/h1-4,7-8H,5-6,9-10H2,(H,21,24)
    Show/Hide
InChIKey
LKVUNZYBZCVWAG-UHFFFAOYSA-N
Physicochemical Property
logP
1.6375
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
69.3
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168273472
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS